Abstract
ObjectivesThis study aims to identify the sources of funding for investigator-initiated clinical trials (IICTs) in Portugal, and to recommend ways to improve the quality of information collected from clinical trial databases about funding.Design and methodsA systematic search of trial registrations over the last 13 years—using the WHO International Clinical Trials Registry Platform (WHO-ICTRP) and four clinical trials registries (CTRs)—was carried out to identify IICTs in Portugal, used as a case study. Data from the databases were compared with data contained in publications to evaluate the consistency of information on funding sources. The term ‘database’ is used in this study to refer to both the WHO-ICTRP and the CTRs. When mentioned separately, the WHO-ICTRP is referred to as a ‘platform’, while the CTRs are referred to as ‘registries’.OutcomeSuggestions to improve clinical trials databases to clearly identify the funding sources and data ownership in IICTs.ResultsTwo hundred and eighty-two IICTs were identified in Portugal. Twenty per cent of trials were supported by industry with unclear information on the ownership of the results. Inaccuracy was found in the information about sponsors and funders. The information about funding in all resulting publications (77 out of 133 completed studies) was also inconsistent between databases in 35 out of 77 (45%) of the studies. Notably, 23% of the trials funded by non-profit organisations (n=226) received funds from international and/or national funding agencies.ConclusionsIdentification of IICT funding and ownership of results is unclear in the databases used for this study, which may lead to misunderstandings about the independence of the obtained results. Transparency and accuracy are desirable so that public decision makers and strategic partners can accurately evaluate national performance in this particular type of clinical research.
Funder
Fundação para a Ciência e Tecnologia
Reference12 articles.
1. Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial)
2. Regulation (EU) Nº 536/2014 of the council parliament and of the council of 16 April 2014 on clinical trials on medicinal products for human use, and replacing Directive 2001/20/EC. https://ec.europa.eu/health/human-use/clinical-trials/regulation
3. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov
4. European Medicines Agency (EMA) Clinical Trials in Human Medicines. https://www.ema.europa.eu/en/human-regulatory/research-development/clinical-trials-human-medicines (Accessed 18 Oct 2018).
5. Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN);Madeira;Contemp Clin Trials Commun,2016
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献